SCHEMBL4673322

SCHEMBL4673322

CC(NS(=O)(=O)N1CCC(Oc2ccc(Cl)cc2)CC1)C(=O)NO

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 2/20 0.59
FPR2 P25090 5/20 0.46
PROKR1 Q8TCW9 5/20 0.46
MMP13 P45452 3/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MMP12 P39900 1/20 0.44
ACACB O00763 1/20 0.44
HRH1 P35367 2/20 0.43
CCR3 P51677 2/20 0.43
KCNH2 Q12809 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
EPHX2 P34913 3/20 0.41
MMP2 P08253 2/20 0.41
ACLY P53396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4673329 1.00 MMP1 (0.59) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4671008 0.89 MMP1 (0.74) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4671004 0.89 MMP1 (0.74) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4675437 0.86 MMP1 (0.54) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4675433 0.86 MMP1 (0.54) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4673324 0.82 MMP1 (0.59) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4673327 0.82 MMP1 (0.59) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4671102 0.81 MMP1 (0.58) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4671106 0.81 MMP1 (0.58) MMP1FPR2PROKR1MMP13MAPT
SCHEMBL4674225 0.81 LMNA (0.59) MMP1FPR2PROKR1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed